Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |